Nephrogenic Systemic Fibrosis, formerly known as nephrogenic fibrosing dermopathy is a condition that only occurs in people with kidney disease.

Nephrogenic Systemic Fibrosis is a systemic disorder with its most prominent effects on the skin. The disorder affects males and females in approximately equal numbers, and though it has been confirmed in children and the elderly it most commonly affects the middle-aged.

Patients with Nephrogenic Systemic Fibrosis describe swelling and tightening of the skin, usually limited to the extremities. The condition may develop and worsen over a period of days to several weeks. In many cases, skin thickening eventually inhibits the flexion and extension of joints. Some patients may be unable to walk, or fully extend the joints of their arms, hands, legs, and feet. Complaints of muscle weakness are also common.

Recently, Nephrogenic Systemic Fibrosis has been linked to gadolinium-based contrast agents used in MRI scans. If you have developed Nephrogenic Systemic Fibrosis after being exposed to such a contrast agent, please contact the gadolinium lawyers of Williams Kherkher by calling 800-761-3187.